News

Select Science
selectscience. net > article > hiarc-launches-hiarc-ctrl-to-accelerate-the-development-of-medical-devices

Hi Arc Ctrl accelerates compliant medtech development - Select Science news

5+ hour, 11+ min ago  (299+ words) Hi Arc Ctrl combines embedded hardware and software tools to streamline prototyping and regulated workflow development Hi Arc Ctrl is suitable for a wide range of application areas, including life sciences, in vitro diagnostics (IVD), robotics, and diagnostics instrumentation. Launch Base…...

Symbols: nasdaq:mbot
Select Science
selectscience. net > article > calla-lily-clinical-care-doses-first-patients-in-clinical-trial-for-intravaginal-drug-delivery

Callavid intravaginal progesterone trial begins - Select Science news

3+ day, 10+ hour ago  (420+ words) Calla Lily Clinical Care's Callavid platform for intravaginal drug delivery Luteal phase insufficiency, where progesterone levels may be too low to sustain early pregnancy, is associated with infertility and recurrent miscarriage. Optimising progesterone delivery is therefore a key focus in…...

Symbols: nasdaq:vtrs
Select Science
selectscience. net > article > 65-of-eligible-lung-cancer-patients-do-not-receive-the-most-appropriate-targeted-therapies

Most a NSCLC patients miss optimal targeted therapy - Select Science news

3+ day, 23+ hour ago  (978+ words) Despite advances in biomarker testing, real-world data shows progress is not translating into treatment decisions, with the largest patient loss now occurring at the point of treatment decision Diaceutics, the intelligence and engagement company focused on unlocking the full potential…...

Symbols: nasdaq:csbr,btc-usd
Select Science
selectscience. net > resource > security-comparison-of-cloud-and-on-premises-informatics-for-hospital-qc-laboratories

Cloud vs on-premises security for hospital QC labs - Select Science resources

3+ day, 18+ hour ago  (118+ words) Security comparison of cloud and on premises informatics for hospital QC laboratories Select Science This whitepaper examines the security differences between cloud'based and on'premises informatics systems for hospital quality control laboratories. It highlights how modern cloud solutions can match or…...

Symbols: btc-usd
Select Science
selectscience. net > video > why-glycosylation-is-the-missing-piece-in-cancer-research

How glycosylation is reshaping cancer research - Select Science interview

4+ day, 16+ hour ago  (137+ words) Why glycosylation is the missing piece in cancer research Select Science Discover how glycobiology is transforming cancer research by revealing critical glycosylation patterns invisible to traditional proteomics. In this Select Science interview, Erica Leonard, Director of R&D at Vector…...

Symbols: btc-usd
Select Science
selectscience. net > article > roche-receives-ce-mark-for-breakthrough-alzheimer-s-plasma-ptau217-blood-test

Roche Elecsys p Tau217 receives CE Mark for Alzheimer's blood test - Select Science news

5+ day, 12+ hour ago  (677+ words) Elecsys p Tau217 is the first single-assay blood test designed to identify or rule out amyloid pathology across primary and secondary care Roche has announced that it has received a CE Mark for Elecsys" p Tau217, a blood test developed in collaboration…...

Symbols: nyse:lh
Select Science
selectscience. net > video > how-bio-techne-is-bridging-cancer-research-spatial-biology-and-diagnostics

How Bio-Techne advances cancer research and diagnostics - Select Science interview

5+ day, 10+ hour ago  (111+ words) How Bio-Techne is bridging cancer research, spatial biology, and diagnostics Select Science Bio'Techne is evolving its approach to support the rapidly changing needs of cancer research. In this Select Science interview, Bio'Techne leaders Steve Crouse and Steve Silverman share how…...

Symbols: nyse:a
Select Science
selectscience. net > article > blood-test-approach-shows-potential-to-predict-disease-progression-and-treatment-response

Blood RNA test predicts disease progression - Select Science news

5+ day, 22+ hour ago  (747+ words) Study demonstrates how RNA'based analysis could enable early prediction of clinical outcomes across multiple conditions An international team of scientists led by Imperial College London has developed a new blood test method, called Velo CD, that can predict how a…...

Symbols: nasdaq:mynz
Select Science
selectscience. net > article > cdc-certification-expands-access-to-gold-standard-equivalent-testosterone-testing-from-siemens

Cdc-certified testosterone testing expands access - Select Science news

1+ week, 10+ hour ago  (379+ words) The Atellica IM TSTII assay, available on the Atellica IM and Atellica CI Analyzers, is currently the only immunoassay with CDC Ho ST-TT certification. The Atellica IM TSTII assay offers a fully automated, routine testing solution on the Atellica IM…...

Symbols: host-tt,nasdaq:stgw
Select Science
selectscience. net > article > myriad-genetics-expands-access-to-mychoice-test-for-prostate-cancer-patients-in-japan

Myriad Genetics expands My Choice test access in Japan - Select Science news

1+ week, 10+ hour ago  (248+ words) Approval by Japan's MHLW enables use of My Choice Test as a companion diagnostic for Lynparza in prostate cancer Myriad Genetics Inc. has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the use of the My…...

Symbols: nasdaq:mygn